Induction of Tolerance and Immunity by Dendritic Cells: Mechanisms and Clinical Applications

by Jitka Fucikova, Jitka Fucikova, Lenka Palova-Jelinkova, Lenka Palova-Jelinkova, Jirina Bartunkova, Jirina Bartunkova, Radek Spisek, Radek Spisek
Published 2019-10-01

Targeting tumor-associated macrophages for successful immunotherapy of ovarian carcinoma

by David Cibula, Iva Truxova, Radek Špíšek, Jitka Fucikova
Published 2023-02-01

Immunological configuration of ovarian carcinoma: features and impact on disease outcome

by Lorenzo Galluzzi, Radek Špíšek, Jitka Fucikova, Sandra Orsulic
Published 2021-10-01

Calreticulin arms NK cells against leukemia

by Jitka Fucikova, Justin P. Kline, Lorenzo Galluzzi, Radek Spisek
Published 2020-01-01

Apoptotic caspases cut down the immunogenicity of radiation

by Aitziber Buqué, Maria Esperanza Rodriguez-Ruiz, Jitka Fucikova, Lorenzo Galluzzi
Published 2019-11-01

Trial watch: Peptide-based vaccines in anticancer therapy

by Lucillia Bezu, Oliver Kepp, Giulia Cerrato, Jonathan Pol, Jitka Fucikova, Radek Spisek, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi
Published 2018-12-01

Converging focal radiation and immunotherapy in a preclinical model of triple negative breast cancer: contribution of VISTA blockade

by Karsten A. Pilones, Michal Hensler, Camille Daviaud, Jeffrey Kraynak, Jitka Fucikova, Lorenzo Galluzzi, Sandra Demaria, Silvia C. Formenti
Published 2020-01-01

Trial Watch: Toll-like receptor agonists in cancer immunotherapy

by Melody Smith, Elena García-Martínez, Michael R. Pitter, Jitka Fucikova, Radek Spisek, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi
Published 2018-12-01

Detection of immunogenic cell death and its relevance for cancer therapy

by Jitka Fucikova, Oliver Kepp, Lenka Kasikova, Giulia Petroni, Takahiro Yamazaki, Peng Liu, Liwei Zhao, Radek Spisek, Guido Kroemer, Lorenzo Galluzzi
Published 2020-11-01

Apoptotic caspases inhibit abscopal responses to radiation and identify a new prognostic biomarker for breast cancer patients

by Maria Esperanza Rodriguez-Ruiz, Aitziber Buqué, Michal Hensler, Jonathan Chen, Norma Bloy, Giulia Petroni, Ai Sato, Takahiro Yamazaki, Jitka Fucikova, Lorenzo Galluzzi
Published 2019-11-01

560 Immunotherapeutic and antimetastatic activity of LTX-315 in preclinical models of ICI-resistant breast cancer

by Xi Zhou, Sandra Demaria, Baldur Sveinbjörnsson, Öystein Rekdal, Erik Wennerberg, Lorenzo Galluzzi, Takahiro Yamazaki, Michal Hensler, Jitka Fucikova, Aitziber Buqué Martinez, Jeffrey Kraynak
Published 2021-11-01

LTX-315-enabled, radiotherapy-boosted immunotherapeutic control of breast cancer by NK cells

by Takahiro Yamazaki, Erik Wennerberg, Michal Hensler, Aitziber Buqué, Jeffrey Kraynak, Jitka Fucikova, Xi Kathy Zhou, Baldur Sveinbjørnsson, Øystein Rekdal, Sandra Demaria, Lorenzo Galluzzi
Published 2021-01-01

Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology

by Isaure Vanmeerbeek, Jenny Sprooten, Dirk De Ruysscher, Sabine Tejpar, Peter Vandenberghe, Jitka Fucikova, Radek Spisek, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi, Abhishek D. Garg
Published 2020-01-01

Dendritic cells pulsed with tumor cells killed by high hydrostatic pressure inhibit prostate tumor growth in TRAMP mice

by Romana Mikyskova, Marie Indrova, Ivan Stepanek, Ivan Kanchev, Jana Bieblova, Sarka Vosahlikova, Irena Moserova, Iva Truxova, Jitka Fucikova, Jirina Bartunkova, Radek Spisek, Radislav Sedlacek, Milan Reinis
Published 2017-12-01

Trial watch: Immune checkpoint blockers for cancer therapy

by Claire Vanpouille-Box, Claire Lhuillier, Lucillia Bezu, Fernando Aranda, Takahiro Yamazaki, Oliver Kepp, Jitka Fucikova, Radek Spisek, Sandra Demaria, Silvia C. Formenti, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi
Published 2017-11-01

TIM-3 levels correlate with enhanced NK cell cytotoxicity and improved clinical outcome in AML patients

by Jana Rakova, Iva Truxova, Peter Holicek, Cyril Salek, Michal Hensler, Lenka Kasikova, Josef Pasulka, Monika Holubova, Marek Kovar, Daniel Lysak, Justin P. Kline, Zdenek Racil, Lorenzo Galluzzi, Radek Spisek, Jitka Fucikova
Published 2021-01-01

Trial Watch: Immunostimulation with recombinant cytokines for cancer therapy

by Elena García-Martínez, Melody Smith, Aitziber Buqué, Fernando Aranda, Francisco Ayala de la Peña, Alejandra Ivars, Manuel Sanchez Cánovas, Ma Angeles Vicente Conesa, Jitka Fucikova, Radek Spisek, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi
Published 2018-06-01

Calreticulin exposure on malignant blasts correlates with improved natural killer cell-mediated cytotoxicity in acute myeloid leukemia patients

by Iva Truxova, Lenka Kasikova, Cyril Salek, Michal Hensler, Daniel Lysak, Peter Holicek, Pavla Bilkova, Monika Holubova, Xiufen Chen, Romana Mikyskova, Milan Reinis, Marek Kovar, Barbora Tomalova, Justin P. Kline, Lorenzo Galluzzi, Radek Spisek, Jitka Fucikova
Published 2020-07-01

Trial Watch: Oncolytic viro-immunotherapy of hematologic and solid tumors

by Jonathan G. Pol, Sarah Lévesque, Samuel T. Workenhe, Shashi Gujar, Fabrice Le Boeuf, Derek R. Clements, Jean-Eudes Fahrner, Laetitia Fend, John C. Bell, Karen L. Mossman, Jitka Fucikova, Radek Spisek, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi
Published 2018-12-01

Calreticulin exposure correlates with robust adaptive antitumor immunity and favorable prognosis in ovarian carcinoma patients

by Lenka Kasikova, Michal Hensler, Iva Truxova, Petr Skapa, Jan Laco, Lucie Belicova, Ivan Praznovec, Sarka Vosahlikova, Michael J. Halaska, Tomas Brtnicky, Lukas Rob, Jiri Presl, Jan Kostun, Isabelle Cremer, Ales Ryska, Guido Kroemer, Lorenzo Galluzzi, Radek Spisek, Jitka Fucikova
Published 2019-11-01